Anaemia in systemic lupus erythematosus: From pathophysiology to clinical assessment

Annals of the Rheumatic Diseases

Volumn 65, Issue 2, 2006, Pages 144-148

  Giannouli, S ^a   Voulgarelis, M ^a   Ziakas, P D ^a   Tzioufas, A G ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CARDIOLIPIN ANTIBODY; CYTOKINE; ERYTHROPOIETIN; ERYTHROPOIETIN ANTIBODY;

ANEMIA; ANTIPHOSPHOLIPID SYNDROME; AUTOIMMUNE HEMOLYTIC ANEMIA; BONE MARROW; CHRONIC DISEASE; DISEASE ASSOCIATION; ERYTHROPOIESIS; HUMAN; IMMUNOREGULATION; KIDNEY DISEASE; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; THROMBOCYTOPENIA; THROMBOSIS;

ANEMIA, HEMOLYTIC, AUTOIMMUNE; AUTOANTIBODIES; ERYTHROPOIETIN; ERYTHROPOIETIN, RECOMBINANT; HEMATOPOIESIS; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; T-LYMPHOCYTES;

EID: 31144445839     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2005.041673     Document Type: Review

References (82)

1. Budman DR, Steinberg AD. Hematologic aspect of systemic lupus erythematosus. Current concepts. Ann Intern Med 1977;86:220-9.
2. Keeling DM, Isenberg DA. Haematological manifestations of systemic lupus erythematosus. Blood Rev 1993;7:199-207.
3. Nossent JC, Swaak AJG. Prevalence and significance of haematological abnormalities in patients with systemic lupus erythematosus. QJM 1991;80:605-12.
4. Delbarre F, Pompidou A, Kahan A, Brouilhet H, Le Go A, Amor B. Study of blood lymphocytes in systemic lupus erythematosus. Pathol Biol 1971;19:379-87.
5. Vlachoyiannopoulos PG, Karasa FB, Karakostas KX, Drosos AA, Moutsopoulos HM. Systemic lupus erythematosus in Greece. Clinical features, evolution and outcome: a descriptive analysis of 292 patients, Lupus 1993;2:303-12.
6. Liu H, Ozaki K, Matsuzaki Y, Abe M, Kosaka M, Saito S. Suppression of haematopoiesis by IgG autoantibodies from patients with systemic lupus erythematosus (SLE). Clin Exp Immunol 1995;100:480-5.
7. Sumimoto S, Kawai M, Kasajima Y, Hamamoto T. Aplastic anemia associated with systemic lupus erythematosus. Am J Hematol 1991;38:329-31.
8. Leddy JP, Falany JL, Kissel GE, Passador ST, Rosenfeld SI. Erythrocyte membrane proteins reactive with human (warm-reacting) anti-red cell autoantibodies. J Clin Invest 1993;91:1672-80.
9. Kaplan MJ. Apoptosis in systemic lupus erythematosus. Clin Immunol 2004;112:210-18.
10. Boackle SA. Complement and autoimmunity. Biomed Pharmacother 2003;57:269-73.
11. Pisetsky DS. The immune response to cell death in SLE. Autoimmun Rev 2004;3:500-4.
12. Okamoto M, Murakami M, Shimizu A, Ozaki S, Tsubata T, Kumagai S, et al. A transgenic model of autoimmune hemolytic anemia. J Exp Med 1992;175:71-9.
13. Victoria EJ, Pierce SW, Branks MJ, Masouredis SP. IgG red blood cell autoantibodies in autoimmune hemolytic anemia bind to epitopes on red blood cell membrane band 3 glycoprotein. J Lab Clin Med 1990;115:74-88.
14. Barker RN, de Sa Oliveira GG, Elson O, Lydyard PM. Pathogenic autoantibodies in the NZB mouse are specific for erythrocyte band 3 protein. Eur J Immunol 1993;23:1723-6.
15. Kay MM, Marchalonis JJ, Hughes J, Watanabe K, Schluter SF. Definition of a physiologic aging autoantigen by using synthetic peptides of membrane protein band 3: localization of the active antigenic sites. Proc Natl Acad Sci USA 1990;87:5734-8.
16. Herrmann M, Voll RE, Zoller OM, Hagenhofer M, Ponner BB, Kalden JR. Impaired phagocytosis of apoptotic cell material by monocyte-derived macrophages from patients with systemic lupus erythematosus. Arthritis Rheum 1998;41:1241-50.
17. Richaud-Patin Y, Perez-Romano B, Carrillo-Maravilla E, Rodriguez AB, Simon AJ, Cabiedes J, et al. Deficiency of red cell bound CD55 and CD59 in patients with systemic lupus erythematosus. Immunol Lett 2003;88:95-9.
18. Lach-Trifilieff E, Marfurt J, Schwarz S, Sadallah S, Schifferli JA. Complement receptor 1 (CD35) on human reticulocytes: normal expression in systemic lupus erythematosus and HIV-infected patients. J Immunol 1999;162:7549-54.
19. Ross GD, Yount WJ, Walport MJ, Winfield JB, Parker CJ, Fuller CR, et al. Disease-associated loss of erythrocyte complement receptors (CR1, C3b receptors) in patients with systemic lupus erythematosus and other diseases involving autoantibodies and/or complement activation. J Immunol 1985;135:2005-14.
20. Alarcon-Segovia D, Deleze M, Oria CV, Sanchez-Guerrero J, Gomez-Pacheco L, Cabiedes J, et al. Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus. A prospective analysis of 500 consecutive patients. Medicine (Baltimore) 1989;68:353-65.
21. Hazeltine M, Rauch J, Danoff D, Esdaile JM, Tannenbaum H. Antiphospholipid antibodies in systemic lupus erythematosus: evidence of an association with positive Coombs' and hypocomplementemia. J Rheumatol 1988;15:80-6.
22. Schleider MA, Nachman RL, Jaffe EA, Coleman M. A clinical study of the lupus anticoagulant. Blood 1976;48:499-509.
23. Deleze M, Oria CV, Alarcon-Segovia D. Occurrence of both hemolytic anemia and thrombocytopenic purpura (Evans' syndrome) in systemic lupus erythematosus. Relationship to antiphospholipid antibodies. J Rheumatol 1988;15:611-15.
24. Cervera R, Font J, Lopez-Soto A, Casals F, Pallares L, Bove A, et al. Isotype distribution of anticardiolipin antibodies in systemic lupus erythematosus: prospective analysis of a series of 100 patients. Ann Rheum Dis 1990;49:109-13.
25. Cabral AR, Cabiedes J, Alarcon-Segovia D. Hemolytic anemia related to an IgM autoantibody to phosphatidylcholine that binds in vitro to stored and to bromelain-treated human erythrocytes. J Autoimmun 1990;3:773-87.
26. Lang B, Straub RH, Weber S, Rother E, Fleck M, Peter HH. Elevated anticadiolipin antibodies in autoimmune haemolytic anaemia irrespective of underlying systemic lupus erythematosus. Lupus 1997;6:652-5.
27. Cheng HM. IgG antiphospholipid autoantibody in normal human sera is reactive against bromelain treated human erythrocytes. J Rheumatol 1993;20:400-1.
28. Ward MM, Pyun E, Studenski S. Mortality risks associated with specific clinical manifestations of systemic lupus erythematosus. Arch Intern Med 1996;156:1337-44.
29. Alger M, Alargon-Segovia D, Riveroa SJ. Hemolytic anemia and thrombocytopenic purpura: two related subsets of systemic lupus erythematosus. J Rheumatol 1997;4:351-7.
30. Drenkard C, Villa AR, Alargon-Segovia D, Perez-Vazquez ME. Influence of the antiphospholipid syndrome in the survival of patients with systemic lupus erythematosus. J Rheumatol 1994;21:1067-72.
31. Sultan SM, Begum S, Isenberg DA. Prevalence, patterns of disease and outcome in patients with systemic lupus erythematosus who develop severe haematological problems. Rheumatology (Oxford) 2003;42:230-4.
32. Kokori SIG, Ioannidis JPA, Tzioufas AG, Voulgarelis M, Moutsopoulos HM. Autoimmune hemolytic anaemia in patients with systemic lupus erythematosus. Am J Med 2000;108:198-204.
33. Sturfelt G, Nived O, Norberg R, Thorstensson R, Krook K. Anticardiolipin antibodies in patients with systemic lupus erythematosus. Arthritis Rheum 1987;30:382-8.
34. Tektonidou MG, Ioannidis JPA, Boki KA, Vlachoyiannopoulos PG, Moutsopoulos HM. Prognostic factors and clustering of serious clinical outcomes in antiphospholipid syndrome. Q J Med 2000;93:523-30.
35. Fong KY, Loizou S, Boey ML, Walport MJ. Anticardiolipin antibodies, haemolytic anaemia and thrombocytopenia in systemic lupus erythematosus. Br J Rheumatol 1992;31:453-5.
36. Gruenberg JC, VanSlyck EJ, Abraham JP. Splenectomy in systemic lupus erythematosis. Am Surg 1986;52:366-70.
37. Pereira RAW, Velloso ERP, Menezes Y, Gualandro S, Vassalo J, Yoshinari NH. Bone marrow findings in systemic lupus erythematosus patients with peripheral cytopenias. Clin Rheumatol 1998;17:219-22.
38. Feng CS, Ng MH, Szeto RS, Li EK. Bone marrow findings in lupus patients with pancytopenia. Pathology 1991;23:5-7.
39. Bailey FA, Lilly M, Bertoli LF, Ball GV. An antibody that inhibits in vitro bone marrow proliferation in a patient with systemic lupus erythematosus and aplastic anemia. Arthritis Rheum 1989;32:901-5.
40. Fitchen JJ, Cline MJ, Saxon A, Golde DW. Serum inhibitors of hematopoiesis in a patient with aplastic anemia and systemic lupus erythematosus. Recovery after exchange plasmapheresis. Am J Med 1979;66:537-42.
41. Brooks BJ Jr, Broxmeyer HE, Bryan CF, Leech SH. Serum inhibitor in systemic lupus erythematosus associated with aplastic anemia. Arch Intern Med 1984;144:1474-7.
42. Kiely PD, McGuckin CP, Collins DA, Bevan DH, Marsh JC. Erythrocyte aplasia and systemic lupus erythematosus. Lupus 1995;4:407-11.
43. Fisch P, Handgretinger R, Schaefer HE. Pure red cell aplasia. Br J Haematol 2000;111:1010-22.
44. Habib GS, Saliba WR, Froom P. Pure red cell aplasia and lupus. Semin Arthritis Rheum 2002;31:279-83.
45. Roffe C, Cahill MR, Samanta A, Bricknell S, Durrant ST. Aplastic anaemia in systemic lupus erythematosus: a cellular immune mechanism? Br J Rheumatol 1991;30:301-4.
46. Mavragani CP, Vlachaki E, Voulgarelis M. Pure red cell aplasia in a Sjogren's syndrome/lupus erythematosus overlap patient. Am J Hematol 2003;72:259-62.
47. Charles RJ, Sabo KM, Kidd PG, Abkowitz JL. The pathophysiology of pure red cell aplasia: implications for therapy. Blood 1996;87:4831-8.
48. Hartman KR, LaRussa VF, Rothwell SW, Atolagbe TO, Ward FT, Klipple G. Antibodies to myeloid precursor cells in autoimmune neutropenia. Blood 1994;84:625-31.
49. Otsuka T, Okamura S, Harada M, Ohhara N, Hayashi S, Yamaga S, et al. Multipotent hemopoietic progenitor cells in patients with systemic lupus erythematosus. J Rheumatol 1988;15:1085-90.
50. Yamasaki K, Niho Y, Yanase T. Erythroid colony forming cells in systemic lupus erythematosus. J Rheumatol 1984;11:167-71.
51. Koyanagawa Y. [A possible role of T cell subsets causing anemia in systemic lupus erythematosus (SLE)]. Hokkaido Igaku Zasshi 1987;62:370-80.
52. Papadaki HA, Boumpas DT, Gibson FM, Jayne DR, Axford JS, Gordon-Smith EC, et al. Increased apoptosis of bone marrow CD34+ cells and impaired function of bone marrow stromal cells in patients with systemic lupus eruthematosus. Br J Haematol 2001;115:167-74.
53. Maciejewski JP, Selleri C, Sato T, Anderson S, Young NS. Increased expression of Fas antigen on bone marrow CD34+ cells of patients with aplastic anaemia. Br J Haematol 1995;91:245-52.
54. Gersuk GM, Beckham C, Loken MR, Kiener P, Anderson JE, Farrand A, et al. A role for tumour necrosis factor-alpha, Fas and Fas-Ligand in marrow failure associated with myelodysplastic syndrome. Br J Haematol 1998;103:176-88.
55. Alvarado-de la Barrera C, Alcocer-Varela J, Richaud-Patin Y, Alarcon-Segovia D, Llorente L. Differential oncogene and TNF-alpha mRNA expression in bone marrow cells from systemic lupus erythematosus patients. Scand J Immunol 1998;48:551-6.
56. Caricchio R, Cohen PL. Spontaneous and induced apoptosis in systemic lupus erythematosus: multiple assays fail to reveal consistent abnormalities. Cell Immunol 1999;198:54-60.
57. Su CC, Shau WY, Wang CR, Chuang CY, Chen CY. CD69 to CD3 ratio of peripheral blood mononuclear cells as a marker to monitor systemic lupus erythematosus disease activity. Lupus 1997;6:449-54.
58. Tiefenthaler M, Bacher N, Linert H, Muhlmann O, Hofer S, Sepp N, et al. Apoptosis of CD34+ cells after incubation with sera of leukopenic patients with systemic lupus erythematosus. Lupus 2003;12:471-8.
59. Otsuka T, Nagasawa K, Harada M, Niho Y. Bone marrow microenvironment of patients with systemic lupus erythematosus. J Rheumatol 1993;20:967-71.
60. Means RT, Krantz SB. Progress in understanding the pathogenesis of the anemia of chronic disease. Blood 1992;80:1639-47.
61. Peeters HR, Jongen-Lavrencic M, Bakker CH, Vreugdenhil G, Breedveld FC, Swaak AJ. Recombinant human erythropoietin improves health-related quality of life in patients with rheumatoid arthritis and anaemia of chronic disease; utility measures correlate strongly with disease activity measures. Rheumatol Int 1999;18:201-6.
62. Schreiber S, Howaldt S, Schnoor M, Nikolaus S, Bauditz J, Gasche C, et al. Recombinant erythropoietin for the treatment of anemia in inflammatory bowel disease. N Engl J Med 1996;334:619-23.
63. Barosi G. Inadequate erythropoietin response to anemia: definition and clinical relevance. Ann Hematol 1994;68:215-23.
64. Faquin WC, Schneider TJ, Goldberg MA. Effect of inflammatory cytokines on hypoxia-induced erythropoietin production. Blood 1992;79:1987-94.
65. Jelkmann W, Pagel H, Wolff M, Fandrey J. Monokines inhibiting erythropoietin production in human hepatoma cultures and in isolated perfused rat kidneys. Life Sci 1992;50:301-8.
66. Schooley JC, Kullgren B, Allison AC. Inhibition by interleukin-1 of the action of erythropoietin on erythroid precursors and its possible role in the pathogenesis of hypoplastic anaemias. Br J Haematol 1987;67:11-17.
67. Means RT Jr, Krantz SB. Inhibition of human erythroid colony-forming units by gamma interferon can be corrected by recombinant human erythropoietin. Blood 1991;78:2564-7.
68. Voulgardis M, Kokori SIG, Ioannidis JPA, Tzioufas AG, Kyriaki D, Moutsopoulos HM. Anaemia in systemic lupus erythematosus: aetiological profile and the role of erythropoietin. Ann Rheum Dis 2000;59:217-22.
69. Caligaris-Cappio F, Bergui L, Tesio L, Ziano R, Camussi G. HLA-DR+T cells of the Leu3 (helper) type infiltrate the kidneys of patients with lupus eythematosus. Clin Exp Immunol 1985;59:185-9.
70. Casadevall N, Dupuy E, Molho-Sabatier P, Tobelem G, Varet B, Mayeux P. Autoantibodies against erythropoietin in a patient with pure red-cell aplasia. N Engl J Med 1996;334:630-3.
71. Schett G, Fibras U, Fureder W, Hiesberger H, Winkler S, Wachauer D, et al. Decreased serum erythropoietin and its relation to anti-erythropoietin antibodies in anaemia of systemic lupus erythematosus. Rheumatology (Oxford) 2001;40:424-31.
72. Casadevall N. Antibodies against rHuEPO: native and recombinant. Nephrol Dial Transplant 2002;17(suppl 5):42-7.
73. Tzioufas AG, Kokori SI, Petrovas CI, Moutsopoulos HM. Autoantibodies to human recombinant eythropoietin in patients with systemic lupus erythematosus: correlation wild anemia. Arthritis Rheum 1997;40:2212-16.
74. Meyer RJ, Hoffman R, Zanjani, eds. Autoimmune hemolytic anemia and periodic pure red cell aplasia in systemic lupus erythematosus. Am J Med 1978;65:342-5.
75. Junca J, Cuxart A, Tural C, Marti S. Systemic lupus eythematosus and pernicious anemia in an 82 old woman. J Rheumatol 1991;18:1924-5.
76. Costello C, Abdelaal M, Coomes EN. Pernicious anemia and systemic lupus eythematosus in a young woman. J Rheumatol 1985;12:798-9.
77. Jimenez-Balderas FJ, Morales-Polanco MR, Gutierrez L. Acute sideroblastic anemia in active systemic lupus erythematosus. Lupus 1994;3:157-9.
78. Kaelin WG Jr, Spivak JL. Systemic lupus erythematosus and myelofibrosis. Am J Med 1986;81:935-8.
79. Wong KF, Hui PK, Chan JK, Chan YW, Ha SY. The acute lupus hemophagocytic syndrome. Ann Intern Med 1991;114:387-90.
80. Nesher G, Hanna VE, Moore TL, Hersh M, Osborn TG. Thrombotic microangiopathic hemolytic anemia in systemic lupus erythematosus. Semin Arthritis Rheum 1994;24:165-72.
81. Bennett CL, Luminari S, Nissenson AR, Tallman MS, Klinge SA, McWilliams N, et al. Pure red-cell aplasia and epoetin therapy. N Engl J Med 2004;351:1403-8.
82. Sennesael JJ, Van der Niepen P, Verbeelen DL. Treatment with recombinant human erythropoietin increases antibody titers after hepatitis B vaccination in dialysis patients. Kidney Int 1991;40:121-8.